EFPIA looks to safeguard public health in ongoing Greek economic crisis

2 July 2015

The European Federation of Pharmaceutical Industries ad Associations (EFPIA) has expressed its concern over the ongoing economic situation in Greece, its potential to have a negative impact on the health service and the possible detrimental effects on the well being of patients in the country.

Against this backdrop, on June 29, the EFPIA sent a letter to European Commissioner Andriukaitis, Commissioner for Health, – copying in Commissioners Bienkowska (Internal Market, Industry, Entrepreneurship, SMEs), Katainen (Vice-President for Jobs, Growth, Investment & Competitiveness), Moscovici (Economic & Financial Affairs, Taxation & Customs) and Vestager (Competition) – emphasising these serious concerns.

The letter highlights two broad categories of issues that could disrupt the supply of medicines were Greece to move towards exiting the Eurozone.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK